2 ms·
The risk of death or serious injury with an investigational product is very low, but it does happen.[1] Clinical trials start after a lot of toxicology screeni
by refurb 6y ago
The risk of death or serious injury with an investigational product is very low, but it does happen.[1]
Clinical trials start after a lot of toxicology screening in vitro and then in animals. For first in human trials, the doses are sub-clinical and then dose-escalation studies are done to find out when adverse events start.
They basically work their way up to therapeutic doses very slowly, monitoring the health of subjects very closely.
[1]https://en.wikipedia.org/wiki/Theralizumab https://en.wikipedia.org/wiki/Theralizumab